‌

US Patent 8652488 Insulin B chain autoantigen composition

Patent 8652488 was granted and assigned to Joslin Diabetes Center (company) on February, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Joslin Diabetes Center (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86524880

Patent Inventor Names

Tihamer Orban0

Date of Patent

February 18, 2014

Patent Application Number

114035800

Date Filed

April 13, 2006

Patent Primary Examiner

‌

Gerald R Ewoldt

Patent abstract

The invention features methods for the prevention or treatment of autoimmune disorders in humans. The methods include administering an autoantigen in combination with an oil-based carrier. Included are methods for the prevention and treatment of diabetes mellitus which include treating a patient with a diabetes type 1 autoantigen, e.g., human insulin B-chain or GAD65, and an oil-based carrier approved for human use. Also included are vaccines and kits for the treatment of diabetes mellitus.